Eosinophils play a central role in the EGPA pathophysiology with blood and tissue eosinophilia as the disease hallmark; IL-5 is recognized as the key mediator in the development and maintenance of this pathogenic finding [8,9]. This evidence concerns the gene IL5 and Increased total eosinophil count.